Autoimmune rheumatic diseases: One or many diseases?

David, 2018, Genetics of immune-mediated inflammatory diseases, Clin. Exp. Immunol., 10.1111/cei.13101 Shukla, 2018, Infections, genetic and environmental factors in pathogenesis of autoimmune thyroid diseases, Microb. Pathog., 116, 279, 10.1016/j.micpath.2018.01.004 Karaiskos, 2009, Stress, coping strategies and social support in patients with primary Sjögren's syndrome prior to disease onset: a retrospective case-control study, Ann. Rheum. Dis., 68, 40, 10.1136/ard.2007.084152 Skopouli, 2018, How stress contributes to autoimmunity-lessons from Sjögren’s syndrome, FEBS Lett., 592, 5, 10.1002/1873-3468.12933 Kroemer, 1991, Cytokines and autoimmune disease, Clin. Immunol. Immunopathol., 61, 275, 10.1016/S0090-1229(05)80001-7 Rosenblum, 2015, Mechanisms of human autoimmunity, J. Clin. Invest., 125, 2228, 10.1172/JCI78088 Hassan, 2021, Classification criteria and clinical practice guidelines for rheumatic diseases Moutsopoulos, 1983, Interferon and autoimmunity, Clin. Exp. Rheumatol., 1, 81 Moutsopoulos, 2007, Sjögren's syndrome or autoimmune epithelitis?, Clin. Rev. Allergy Immunol., 32, 199, 10.1007/s12016-007-8042-1 Moutsopoulos, 2014, Sjögren's syndrome: a forty-year scientific journey, J. Autoimmun., 51, 1, 10.1016/j.jaut.2014.01.001 Vlachoyiannopoulos, 1998, Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic, J. Rheumatol., 25, 886 Albrecht, 2017, Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies, Arthritis Res. Ther., 19, 68, 10.1186/s13075-017-1266-4 Ioannidis, 2000, Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide, Kidney Int., 57, 258, 10.1046/j.1523-1755.2000.00832.x Fragkioudaki, 2016, Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use, Medicine (Baltim.), 95 Cinoku, 2021, Interferon (IFN)-stimulated gene 15: a novel biomarker for lymphoma development in Sjögren's syndrome, J. Autoimmun., 123, 102704, 10.1016/j.jaut.2021.102704 Tzelepis, 2010, Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis, Eur. Respir. J., 36, 116, 10.1183/09031936.00110109 Sharp, 1972, Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA), Am. J. Med., 52, 148, 10.1016/0002-9343(72)90064-2 Iaccarino, 2013, Overlap connective tissue disease syndromes. Autoimmunity Reviews, 12, 363 Hanke, 2009, Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients, Arthritis Res. Ther., 11, R22, 10.1186/ar2614 Andonopoulos, 1987, Secondary Sjögren's syndrome in rheumatoid arthritis, J. Rheumatol., 14, 1098 Moutsopoulos, 1979, Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis, Am. J. Med., 66, 733, 10.1016/0002-9343(79)91110-0 Manoussakis, 2004, Sjögren’s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren’s syndrome, Arthritis Rheum., 50, 882, 10.1002/art.20093 Turkcapar, 2006, A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjögren's syndrome, Rheumatol. Int., 26, 841, 10.1007/s00296-005-0084-1 Zampeli, 2019, Evolution of one systemic rheumatic disease into another: scleroderma evolving to eosinophilic fasciitis with myositis, Clin. Exp. Rheumatol., 37, 149 Ulff-Møller, 2018, Concordance of autoimmune disease in a nationwide Danish systemic lupus erythematosus twin cohort, Semin. Arthritis Rheum., 47, 538, 10.1016/j.semarthrit.2017.06.007 Pers, 2021, Autoimmune rheumatic disorders: pathogenetic and laboratory aspects, 35 Mavragani, 2016, Crow MK expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease, Arthritis Rheum., 68, 2686, 10.1002/art.39795 Mavragani, 2018, Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: role of methylating enzymes, J. Autoimmun., 88, 75, 10.1016/j.jaut.2017.10.004 Kordossis, 1998, Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology, Br. J. Rheumatol., 37, 691, 10.1093/rheumatology/37.6.691 Dimitrakopoulos, 1999, Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1, Ann. Intern. Med., 130, 226, 10.7326/0003-4819-130-3-199902020-00027 Hoofnagle, 2003, 155 Rodríguez, 2020, Autoinflammatory and autoimmune conditions at the crossroad of COVID-19, J. Autoimmun., 114, 102506, 10.1016/j.jaut.2020.102506 Bradshaw, 2015, Herpes simplex virus 1 encephalitis associated with voltage-gated calcium channel autoimmunity, Neurology, 85, 2176, 10.1212/WNL.0000000000002218 Cabibi, 2008, Autoimmune hepatitis following Epstein–Barr virus infection, BMJ Case Rep., 2008, 10.1136/bcr.06.2008.0071 Fairweather, 2007, Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity, Methods, 41, 118, 10.1016/j.ymeth.2006.07.009 Triantafyllopoulou, 2004, Evidence for coxsackievirus infection in primary Sjögren's syndrome, Arthritis Rheum., 50, 2897, 10.1002/art.20463 Karagianni, 2019, West Nile Virus infection triggering autoimmune encephalitis: Pathophysiological and therapeutic implications. Clinical Immunology Lerner, 2017, Microbes and viruses are bugging the gut in celiac disease. Are they friends or foes?, Front. Microbiol., 8, 1392, 10.3389/fmicb.2017.01392 Zampeli, 2020, Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations, Clin. Exp. Rheumatol., 38, 134 Pers, 2021, Autoimmune rheumatic disorders: pathogenetic and laboratory aspects, 38 Arbuckle, 2003, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N. Engl. J. Med., 349, 1526, 10.1056/NEJMoa021933 Rider, 2016, Biologics for targeting inflammatory cytokines, clinical uses, and limitations, IntJ Cell Biol, 2016, 9259646 Zampeli, 2017, A comprehensive evaluation for the treatment of lupus nephritis, J. Autoimmun., 78, 1, 10.1016/j.jaut.2016.12.011